Estadificación del cáncer de colon: ganglios linfáticos

1.    American Cancer Society: Colorectal Cancer Facts and Figures 2011−2013. American Cancer Society Inc. Atlanta, GA2013.:Available at:http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-028323.pdf
2.    Moertel C.G., Fleming T.R., Macdonald J.S., et al:  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.  N Engl J Med 322. 352-358.1990;
3.    Edge S, Byrd DR, Compton CC, eds. Colon and rectum. In: AJCC Cancer Staging Manual. 7th ed. New York: Springer-Verlag; 2010:143–164.
4.    National Quality Forum: NQF Endorses Additional Cancer Measures. National Quality Forum Washington, DC2012. Available at:http://www.qualityforum.org/News_And_Resources/Press_Releases/2012/NQF_Endorses_Additional_Cancer_Measures.aspx
5.    Le Voyer T.E., Sigurdson E.R., Hanlon A.L., et al:  Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.  J Clin Oncol 21. 2912-2919.2003;
6.    Namm J., Ng M., Roy-Chowdhury S., et al:  Quantitating the impact of stage migration on staging accuracy in colorectal cancer.  J Am Coll Surg 207. 882-887.2008;
7.    Cserni G., Vinh-Hung V., Burzykowski T.:  Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?.  J Surg Oncol 81. 63-69.2002;
8.    Wong J.H., Severino R., Honnebier M.B., et al:  Number of nodes examined and staging accuracy in colorectal carcinoma.  J Clin Oncol 17. 2896-2900.1999;
9.    Goldstein N.S., Sanford W., Coffey M., Layfield L.J.:  Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered.  Am J Clin Pathol 106. 209-216.1996; 
10.    Baxter N.N., Virnig D.J., Rothenberger D.A., et al:  Lymph node evaluation in colorectal cancer patients: a population-based study.  J Natl Cancer Inst 97. 219-225.2005;
11.    Parsons H.M., Tuttle T.M., Kuntz K.M., et al:  Association between lymph node evaluation for colon cancer and node positivity over the past 20 years.  JAMA 306. 1089-1097.2011; 
12.    Wong S.L., Ji H., Hollenbeck B.K., et al:  Hospital lymph node examination rates and survival after resection for colon cancer.  JAMA 298. 2149-2154.2007; 
13.    Bui L., Rempel E., Reeson D., Simunovic M.:  Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study.  J Surg Oncol 93. 439-445.2006;
14.    Wong J.H., Lum S.S., Morgan J.W.:  Lymph node counts as an indicator of quality at the hospital level in colorectal surgery.  J Am Coll Surg 213. 226-230.2011;
15.    Sjo O.H., Merok M.A., Svindland A., Nesbakken A.:  Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer.  Dis Colon Rectum 55. 307-315.2012; 
16.    Cunningham D., Atkin W., Lenz H.J., et al:  Colorectal cancer.  Lancet 375. 1030-1047.2010; 
17.    Trombold J., Farmer R.W., McCafferty M.:  The impact of colorectal cancer screening in a veteran hospital population.  Am Surg 79. 296-300.2013; 
18.    Jemal A., Siegel R., Ward E., et al:  Cancer statistics, 2008.  CA Cancer J Clin 58. 71-96.2008; 
19.    Prenen H., Vecchione L., Van Cutsem E.:  Role of targeted agents in metastatic colorectal cancer.  Targeted Oncol 8. 83-96.2013